NGNE — NEUROGENE INC

Ownership history in XTX Topco Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in NEUROGENE INC (NGNE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2024 Q4)
Avg. % of fund
0.02%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 12,000 -3,256 -21.3% 0.01% $208K $17.33
2024 Q4 INITIATED 15,256 — — 0.03% $349K $22.86
% of Fund (quarterly)    NGNE price (monthly, adj. close)

Other funds also holding NGNE

As of 2025 Q4 — sorted by position size

Samsara BioCapital, LLC 3Y 7Y 3.65% GREAT POINT PARTNERS LLC 3Y 7Y 2.34% Redmile Group, LLC 3Y 7Y 2.21% Casdin Capital, LLC 3Y 7Y 1.66% EcoR1 Capital, LLC 3Y 7Y 1.19% RTW INVESTMENTS, LP 3Y 7Y 0.28% ArrowMark Colorado Holdings LLC 3Y 7Y 0.26% Logos Global Management LP 3Y 0.24% DAFNA Capital Management LLC 3Y 7Y 0.13% BAKER BROS. ADVISORS LP 3Y 7Y 0.12%
← Back to XTX Topco Ltd Holdings